No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Edarbyclor is a combination of two drugs, azilsartan medoxomil and chlorthalidone, used to treat hypertension and reduce the risk of cardiovascular disease. It is a once-daily medication that works by blocking the action of certain hormones that cause blood vessels to constrict, thus lowering blood pressure. It is also used to reduce the risk of stroke, heart attack, and other cardiovascular events. Edarbyclor is available in both generic and brand-name formulations.
The Edarbyclor market is highly competitive, with a number of pharmaceutical companies offering their own versions of the drug. These companies include Merck, Daiichi Sankyo, Teva Pharmaceuticals, and Mylan. Other companies, such as Sun Pharmaceuticals, Lupin, and Glenmark, also offer generic versions of the drug. All of these companies are committed to providing quality products to their customers. Show Less Read more
